OrganiGram Holdings's EBIT is $-17M, below the Healthcare sector average of $22B.
Get informed when a big investor buys or sells
+ FollowAs of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026
OrganiGram Holdings (OGI) currently reports a EBIT of $-17M as of March 2026. That compares with $-29M in the prior-year period — up 41.3% year over year. That is below the Healthcare sector average of $22B. Use the charts on this page to explore OrganiGram Holdings's EBIT history and peer comparisons.
OrganiGram Holdings's EBIT increased from $-29M to $-17M — a 41.3% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
OrganiGram Holdings's EBIT of $-17M is lower than the Healthcare sector average of $22B. That is roughly 100.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
OrganiGram Holdings reported $-17M in EBIT as of March 2026. That compares with $-29M in the prior-year period — up 41.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current EBIT of $-17M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $22B. From there, open related valuation or income-statement pages for OrganiGram Holdings, and consider following OGI for alerts when major investors trade the stock.